What is Woundtech?
Woundtech is a specialized provider of advanced, personalized mobile wound care services, delivering expert treatment directly to patients' homes. Founded in 1999, the company leverages evidence-based solutions and proprietary products to address the unique needs of patients with complex wounds, having facilitated over 2 million patient encounters. By partnering with insurance providers, Woundtech enhances the accessibility of its specialized care, focusing on patient-centered outcomes and aiming to reduce overall healthcare costs through efficient, home-based interventions.
How much funding has Woundtech raised?
Woundtech has raised a total of $40M across 1 funding round:
Series A
$40M
Series A (2016): $40M with participation from Aldrich Capital Partners
Key Investors in Woundtech
Aldrich Capital Partners
Aldrich Capital Partners is a growth equity firm that supports ambitious, founder-run companies. With over $1.2 billion in assets under management, they provide growth-oriented equity and expertise to help companies scale.
What's next for Woundtech?
The substantial enterprise-level funding, including the strategic investment in 2016, positions Woundtech for continued expansion and innovation in the mobile healthcare delivery space. This capital infusion is likely to fuel advancements in their proprietary technologies, broaden their service reach to more patient populations, and strengthen partnerships with healthcare payers. The company's focus on improving patient outcomes and reducing healthcare expenditures aligns with current market trends, suggesting a strategic path toward increased market share and operational efficiency.
See full Woundtech company page
